Evidence map›Paper›PMID 37701051›Full record

ArticleFrontiers in chemistry2023

Experimental and theoretical investigations of Erbium complex: DNA/BSA interaction, anticancer and antibacterial studies.

Raid D Thanoon, Emam Atiyah Ibadi, Irfan Ahmad, Hassan Thoulfikar A Alamir, Marim Alwan, Furqan S Hashim, Donia Waleed Khaled, Adnan Taan Alkhafaji, Mohammed Asiri, Ali Alsaalamy

RetractedAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Raid D ThanoonDepartment of Medical Biochemical Analysis, Cihan University-Erbil, Kurdistan Region, Iraq.
Emam Atiyah IbadiDepartment of Pharmacy, Al-Mustaqbal University College, Babylon, Iraq.
Irfan AhmadDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
Hassan Thoulfikar A AlamirDepartment of Pharmaceutics, Faculty of Pharmacy, University of Al-Ameed, Karbala, Iraq.
Marim AlwanMedical Lab Techniques, College of Medical Technology, Al-Farahidi University, Baghdad, Iraq.
Furqan S HashimDepartment of Medical Laboratories Technology, Al-Nisour University College, Baghdad, Iraq.
Donia Waleed KhaledDepartment of Optical Techniques, AlNoor University College, Mosul, Iraq.
Adnan Taan AlkhafajiCardiology Department, College of Medicine, Al-Ayen University, Nasiriyah, Iraq.
Mohammed AsiriDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
Ali AlsaalamyCollege of Technical Engineering, Imam Ja'afar Al-Sadiq University, Baghdad, Iraq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the biological potential of an Er complex that contains a 2,2'-bipyridine ligand, various techniques such as multispectral and molecular modeling procedures were utilized to examine its DNA-binding ability, BSA binding affinity, antimicrobial effects, and anticancer properties. By analyzing fluorescent information and employing the vant' Hoff equation, important parameters such as the innate docking coefficient (K

Indexed as

anticancer propertiesantimicrobial propertiesDNA and BSA bindingEr complexmolecular docking

Identifiers

PMID37701051
PMCPMC10493310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.